Probiotical S.p.a.

Alce North America, Inc.

Marco Pane

Angela Amoruso

Mirta Fiorio

Angela Marotta

Giovanna Felis

Antonio Del Casale

Giovanni Mogna

Gian Paolo Strozzi

Vera Mogna

Ciro Costagliola

Serena Allesina

The present invention relates to mixtures, or compositions comprising said mixtures, comprising at least one bacterial strain, preferably at least one probiotic bacterial strain or a derivative thereof, as well as to the use of said mixtures or compositions in methods for the preventive and/or curative treatment of an inflammatory ocular and/or periocular lesion, preferably in methods for the treatment of ocular diseases such as dry eyes, eyelid allergy, conjunctivitis, blepharitis, meibonite, dacryoliths, stye, inflammatory lesions of ocular adnexa and associated symptoms.

Compositions comprising bacterial strains and use thereof for the treatment of ocular diseases and lesions

An isolated strain of bacteria(B632) DSM 24706 and related mixtures, compositions and methods for treatment of a disorder or an ailment or a disease of the respiratory airways including asthma and dyspnoea are described. The composition comprising the mixture includes at least one physiologically and/or pharmacologically acceptable additive and/or technological excipient. The isolated strain mixture and composition can be administered to paediatric subjects having a disorder or an ailment or a disease of the respiratory airways.

Mixture of probiotic bacteria strains for use in the treatment of allergic asthma and with recurrent wheezing, preferably in paediatric subjects

The present invention refers to a composition for use in the treatment of sleep disorder, in particular, in the improvement of sleep quality. Furthermore, the present invention refers to a composition for use in the treatment of mood modulation.

Composition for use in the treatment and/or improvement of sleep and mood disorders

The present invention relates to conjugated linoleic acid (CLA)-producing strains of probiotic bacteria. In particular, the present invention relates to a selection of bacterial strains belonging to the genuswhich were selected for their ability to produce conjugated linoleic acid (CLA) from linoleic acid (LA). Furthermore, the present invention relates to a food, dietetic or pharmaceutical composition comprising said bacterial strains capable of increasing the quantity of CLA in situ, i.e. inside the gastrointestinal tract.

Conjugated linoleic acid-producing strains of probiotic bacteria and use thereof for the preparation of a food, dietetic or pharmaceutical composition

Growing community of inventors

Novara, Italy

Marco Pane